Elnaz Agi

498 total citations
32 papers, 375 citations indexed

About

Elnaz Agi is a scholar working on Molecular Biology, Immunology and Virology. According to data from OpenAlex, Elnaz Agi has authored 32 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Immunology and 10 papers in Virology. Recurrent topics in Elnaz Agi's work include Immunotherapy and Immune Responses (14 papers), HIV Research and Treatment (10 papers) and vaccines and immunoinformatics approaches (9 papers). Elnaz Agi is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), HIV Research and Treatment (10 papers) and vaccines and immunoinformatics approaches (9 papers). Elnaz Agi collaborates with scholars based in Iran, Malaysia and Germany. Elnaz Agi's co-authors include Azam Bolhassani, Ali Namvar, Seyed Mehdi Sadat, Sepideh Shahbazi, Rouhollah Vahabpour, Noushin Davoudi, Kimia Kardani, Alireza Milani, Nooshin Haghighipour and Amin Hadi and has published in prestigious journals such as PLoS ONE, Journal of Pharmaceutical Sciences and Clinica Chimica Acta.

In The Last Decade

Elnaz Agi

30 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elnaz Agi Iran 11 220 133 79 64 39 32 375
Samuel E. Moretz United States 11 215 1.0× 227 1.7× 63 0.8× 39 0.6× 60 1.5× 17 705
Murray Skinner United Kingdom 16 93 0.4× 142 1.1× 54 0.7× 65 1.0× 27 0.7× 43 650
Amanda B. Lasnik United States 11 194 0.9× 180 1.4× 82 1.0× 109 1.7× 54 1.4× 14 545
Tanja Breinig Germany 12 151 0.7× 128 1.0× 37 0.5× 44 0.7× 29 0.7× 15 353
Victoria Majam United States 17 214 1.0× 322 2.4× 128 1.6× 79 1.2× 56 1.4× 32 759
Adrián Vilalta United States 12 264 1.2× 125 0.9× 142 1.8× 71 1.1× 42 1.1× 21 454
Max Søgaard Denmark 12 468 2.1× 95 0.7× 70 0.9× 96 1.5× 16 0.4× 17 657
Roger Astley United States 18 230 1.0× 172 1.3× 75 0.9× 43 0.7× 19 0.5× 33 690
Ina Baļķe Latvia 12 128 0.6× 112 0.8× 49 0.6× 98 1.5× 22 0.6× 26 484

Countries citing papers authored by Elnaz Agi

Since Specialization
Citations

This map shows the geographic impact of Elnaz Agi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elnaz Agi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elnaz Agi more than expected).

Fields of papers citing papers by Elnaz Agi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elnaz Agi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elnaz Agi. The network helps show where Elnaz Agi may publish in the future.

Co-authorship network of co-authors of Elnaz Agi

This figure shows the co-authorship network connecting the top 25 collaborators of Elnaz Agi. A scholar is included among the top collaborators of Elnaz Agi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elnaz Agi. Elnaz Agi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Milani, Alireza, et al.. (2025). Immunostimulatory effects of Hsp70 fragments-modified DCs: A computational and experimental study in HIV vaccine design. Microbes and Infection. 27(4). 105480–105480. 1 indexed citations
2.
Agi, Elnaz, et al.. (2025). Antitumor Effects of HPV E7 and L1-E7 Multiepitope DNA Constructs Delivered by Synthetic and Arginine-Rich Cell Penetrating Peptides. International Journal of Peptide Research and Therapeutics. 31(2).
3.
Mohit, Elham, et al.. (2024). Engineered ClearColi™-derived outer membrane vesicles as functional carriers for development of HIV-1 therapeutic vaccine candidate. Microbial Pathogenesis. 193. 106749–106749. 5 indexed citations
4.
Milani, Alireza, et al.. (2022). Different dendritic cells-based vaccine constructs influence HIV-1 antigen-specific immunological responses and cytokine generation in virion-exposed splenocytes. International Immunopharmacology. 113(Pt A). 109406–109406. 4 indexed citations
5.
Bolhassani, Azam, et al.. (2022). Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen. PLoS ONE. 17(6). e0268251–e0268251. 19 indexed citations
6.
7.
Mirabzadeh, Esmat, et al.. (2021). Expression of a Novel HIV-1 Gag-Pol-Env-Nef-Rev Multi-Epitope Construct in Escherichia coli. 9(2). 62–70. 1 indexed citations
8.
Milani, Alireza, et al.. (2021). HIV-1 Accessory Proteins: Which one is Potentially Effective in Diagnosis and Vaccine Development?. Protein and Peptide Letters. 28(6). 687–698. 4 indexed citations
9.
Agi, Elnaz, et al.. (2020). Genotyping of intron 1 and 22 inversion of factor VIII gene using IS-PCR in Kurdish patients of Iraq. Eurasian Journal of Biosciences. 14(1). 1181–1185. 1 indexed citations
10.
11.
Namvar, Ali, et al.. (2020). Development of HPV16,18,31,45 E5 and E7 peptides-based vaccines predicted by immunoinformatics tools. Biotechnology Letters. 42(3). 403–418. 36 indexed citations
12.
Kardani, Kimia, Azam Bolhassani, Elnaz Agi, & Atieh Hashemi. (2020). B1 protein: a novel cell penetrating protein for in vitro and in vivo delivery of HIV-1 multi-epitope DNA constructs. Biotechnology Letters. 42(10). 1847–1863. 5 indexed citations
13.
Milani, Alireza, et al.. (2020). Pharmaceutical Approaches for Treatment of Hepatitis C virus. Current Pharmaceutical Design. 26(34). 4304–4314. 6 indexed citations
14.
Bolhassani, Azam & Elnaz Agi. (2019). Heat shock proteins in infection. Clinica Chimica Acta. 498. 90–100. 100 indexed citations
15.
Bolhassani, Azam, Sepideh Shahbazi, Elnaz Agi, et al.. (2019). Modified DCs and MSCs with HPV E7 antigen and small Hsps: Which one is the most potent strategy for eradication of tumors?. Molecular Immunology. 108. 102–110. 21 indexed citations
16.
17.
Bolhassani, Azam, et al.. (2015). VLP production in Leishmania tarentolae : A novel expression system for purification and assembly of HPV16 L1. Protein Expression and Purification. 116. 7–11. 18 indexed citations
18.
Bolhassani, Azam, Kimia Kardani, Rouhollah Vahabpour, et al.. (2015). Prime/boost immunization with HIV-1 MPER-V3 fusion construct enhances humoral and cellular immune responses. Immunology Letters. 168(2). 366–373. 23 indexed citations
19.
20.
Rafati, Sima, Farnaz Zahedifard, Fatemeh Doustdari, et al.. (2012). HPV16 E7-CT (gp96) fusion protein: Molecular cloning, expression and purification of a recombinant 6xHis-tagged protein in E. coli. Journal of paramedical sciences.. 3(2). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel E. Moretz Breakdown of academic impact, for papers by Murray Skinner Breakdown of academic impact, for papers by Amanda B. Lasnik Breakdown of academic impact, for papers by Tanja Breinig Breakdown of academic impact, for papers by Victoria Majam Breakdown of academic impact, for papers by Adrián Vilalta Breakdown of academic impact, for papers by Max Søgaard Breakdown of academic impact, for papers by Roger Astley Breakdown of academic impact, for papers by Ina Baļķe
Rankless by CCL
2026